$28.15
-0.07-0.25%
After Hours: Jul 19, 5:45 PM EDT
15 minutes delayed
Comments
Loading...
Doximity
DOCSNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Doximity (NYSE:DOCS) Stock, Analyst Ratings, Price Targets, Forecasts
Doximity Inc has a consensus price target of $39.95 based on the ratings of 24 analysts. The high is $72 issued by SVB Leerink on November 10, 2021. The low is $19 issued by Wells Fargo on July 18, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Evercore ISI Group, and JP Morgan on July 18, 2024, May 17, 2024, and April 25, 2024, respectively. With an average price target of $24.33 between Wells Fargo, Evercore ISI Group, and JP Morgan, there's an implied -15.11% downside for Doximity Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Evercore ISI Group
JP Morgan
Morgan Stanley
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for Doximity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/18/2024 | Buy Now | -33.72% | Wells Fargo | Stan Berenshteyn | $27 → $19 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 05/17/2024 | Buy Now | — | Needham | Scott Berg | — | Reiterates | → Hold | Get Alert |
| 05/17/2024 | Buy Now | 1.17% | Evercore ISI Group | Elizabeth Anderson | $28 → $29 | Maintains | In-Line | Get Alert |
| 04/25/2024 | Buy Now | -12.79% | JP Morgan | Anne Samuel | → $25 | Upgrade | Underweight → Neutral | Get Alert |
| 04/23/2024 | Buy Now | -12.79% | Morgan Stanley | Ricky Goldwasser | $25 → $25 | Maintains | Underweight | Get Alert |
| 04/02/2024 | Buy Now | 4.66% | Evercore ISI Group | Elizabeth Anderson | → $30 | Maintains | In-Line | Get Alert |
| 03/15/2024 | Buy Now | -12.79% | JP Morgan | Anne Samuel | $22 → $25 | Maintains | Underweight | Get Alert |
| 02/26/2024 | Buy Now | 11.63% | Leerink Partners | Michael Cherny | → $32 | Initiates | → Market Perform | Get Alert |
| 02/09/2024 | Buy Now | 1.17% | Truist Securities | Jailendra Singh | $28 → $29 | Maintains | Hold | Get Alert |
| 02/09/2024 | Buy Now | -5.81% | Wells Fargo | Stan Berenshteyn | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | Buy Now | 11.63% | B of A Securities | Allen Lutz | $29 → $32 | Maintains | Neutral | Get Alert |
| 01/02/2024 | Buy Now | 1.17% | B of A Securities | Allen Lutz | $21 → $29 | Upgrade | Underperform → Neutral | Get Alert |
| 11/10/2023 | Buy Now | -19.76% | Piper Sandler | Jessica Tassan | $21 → $23 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | -12.79% | Morgan Stanley | Ricky Goldwasser | $21 → $25 | Maintains | Underweight | Get Alert |
| 09/05/2023 | Buy Now | 15.12% | Canaccord Genuity | Richard Close | $40 → $33 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | -12.79% | Wells Fargo | Stan Berenshteyn | $37 → $25 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | -2.32% | Truist Securities | Jailendra Singh | $33 → $28 | Maintains | Hold | Get Alert |
| 08/09/2023 | Buy Now | -26.74% | Morgan Stanley | Ricky Goldwasser | $28 → $21 | Maintains | Underweight | Get Alert |
| 08/09/2023 | Buy Now | — | Guggenheim | Sandy Draper | — | Downgrade | Buy → Neutral | Get Alert |
| 08/09/2023 | Buy Now | 4.66% | Raymond James | Brian Peterson | $40 → $30 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | — | Needham | Scott Berg | — | Downgrade | Buy → Hold | Get Alert |
| 08/03/2023 | Buy Now | 25.59% | Piper Sandler | Jessica Tassan | $38 → $36 | Downgrade | Overweight → Neutral | Get Alert |
| 06/07/2023 | Buy Now | 39.54% | Canaccord Genuity | Richard Close | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | Buy Now | 56.99% | Needham | Scott Berg | → $45 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 15.12% | Truist Securities | Jailendra Singh | $36 → $33 | Maintains | Hold | Get Alert |
| 05/17/2023 | Buy Now | 39.54% | Canaccord Genuity | Richard Close | $41 → $40 | Maintains | Buy | Get Alert |
| 05/17/2023 | Buy Now | 11.63% | Evercore ISI Group | Elizabeth Anderson | $33 → $32 | Maintains | In-Line | Get Alert |
| 05/17/2023 | Buy Now | -2.32% | Morgan Stanley | Ricky Goldwasser | $29 → $28 | Maintains | Underweight | Get Alert |
| 05/17/2023 | Buy Now | 56.99% | Needham | Scott Berg | → $45 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2023 | Buy Now | 29.08% | Wells Fargo | Stan Berenshteyn | $39 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/17/2023 | Buy Now | 4.66% | JP Morgan | Anne Samuel | $60 → $30 | Maintains | Underweight | Get Alert |
| 02/10/2023 | Buy Now | 36.05% | Wells Fargo | Stan Berenshteyn | $44 → $39 | Maintains | Overweight | Get Alert |
| 02/10/2023 | Buy Now | 43.03% | Canaccord Genuity | Richard Close | $42 → $41 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 56.99% | Needham | Scott Berg | → $45 | Reiterates | → Buy | Get Alert |
| 01/06/2023 | Buy Now | 1.17% | Morgan Stanley | Ricky Goldwasser | $32 → $29 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/11/2022 | Buy Now | 53.5% | Wells Fargo | Stan Berenshteyn | $38 → $44 | Maintains | Overweight | Get Alert |
| 10/31/2022 | Buy Now | 32.57% | Wells Fargo | Stan Berenshteyn | → $38 | Initiates | → Overweight | Get Alert |
| 10/24/2022 | Buy Now | -2.32% | Evercore ISI Group | Elizabeth Anderson | → $28 | Initiates | → In-Line | Get Alert |
| 10/13/2022 | Buy Now | — | BTIG | David Larsen | — | Initiates | → Neutral | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | — | — | Initiates | → Sector Weight | Get Alert |
| 09/07/2022 | Buy Now | 22.1% | Truist Securities | Jailendra Singh | → $35 | Initiates | → Hold | Get Alert |
| 08/08/2022 | Buy Now | 60.47% | Goldman Sachs | Cindy Motz | $53 → $46 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 46.52% | Canaccord Genuity | Richard Close | $47 → $42 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 1.17% | B of A Securities | Allen Lutz | $43 → $29 | Downgrade | Neutral → Underperform | Get Alert |
| 08/05/2022 | Buy Now | 36.05% | Piper Sandler | Jessica Tassan | $44 → $39 | Maintains | Overweight | Get Alert |
| 07/29/2022 | Buy Now | 70.94% | Berenberg | Dev Weerasuriya | → $49 | Initiates | → Buy | Get Alert |
| 07/28/2022 | Buy Now | 70.94% | Berenberg | Dev Weerasuriya | → $49 | Initiates | → Buy | Get Alert |
| 05/19/2022 | Buy Now | 95.36% | Goldman Sachs | Cindy Motz | $72 → $56 | Maintains | Buy | Get Alert |
| 05/19/2022 | Buy Now | 53.5% | Piper Sandler | Sean Wieland | $81 → $44 | Maintains | Overweight | Get Alert |
| 05/18/2022 | Buy Now | 81.41% | Guggenheim | Sandy Draper | $70 → $52 | Maintains | Buy | Get Alert |
| 05/18/2022 | Buy Now | 60.47% | Jefferies | Glen Santangelo | $78 → $46 | Maintains | Buy | Get Alert |
| 05/18/2022 | Buy Now | 39.54% | Raymond James | Brian Peterson | $60 → $40 | Maintains | Outperform | Get Alert |
| 05/18/2022 | Buy Now | 22.1% | Morgan Stanley | Craig Hettenbach | $55 → $35 | Maintains | Equal-Weight | Get Alert |
| 05/18/2022 | Buy Now | 56.99% | Baird | Vikram Kesavabhotla | $68 → $45 | Maintains | Outperform | Get Alert |
| 05/18/2022 | Buy Now | 56.99% | Needham | Scott Berg | $70 → $45 | Maintains | Buy | Get Alert |
| 05/18/2022 | Buy Now | 133.73% | SVB Leerink | Stephanie Davis | $72 → $67 | Maintains | Outperform | Get Alert |
| 04/07/2022 | Buy Now | 144.2% | Guggenheim | Sandy Draper | → $70 | Initiates | → Buy | Get Alert |
| 04/04/2022 | Buy Now | 91.87% | B of A Securities | Allen Lutz | → $55 | Initiates | → Neutral | Get Alert |
| 03/23/2022 | Buy Now | 91.87% | Morgan Stanley | Craig Hettenbach | $62 → $55 | Maintains | Equal-Weight | Get Alert |
| 02/11/2022 | Buy Now | 158.15% | Goldman Sachs | Cindy Motz | → $74 | Initiates | → Buy | Get Alert |
| 02/09/2022 | Buy Now | 109.31% | Raymond James | Brian Peterson | $80 → $60 | Maintains | Outperform | Get Alert |
| 02/09/2022 | Buy Now | 144.2% | Needham | Scott Berg | $90 → $70 | Maintains | Buy | Get Alert |
| 12/17/2021 | Buy Now | 102.34% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 12/14/2021 | Buy Now | 109.31% | JP Morgan | Jackson Ader | — | Downgrade | Neutral → Underweight | Get Alert |
| 12/02/2021 | Buy Now | 172.11% | Jefferies | Glen Santangelo | — | Initiates | → Buy | Get Alert |
| 11/17/2021 | Buy Now | 193.04% | Baird | Vikram Kesavabhotla | — | Initiates | → Outperform | Get Alert |
| 11/10/2021 | Buy Now | 179.09% | Raymond James | Brian Peterson | — | Maintains | Outperform | Get Alert |
| 11/10/2021 | Buy Now | 213.97% | Needham | Scott Berg | — | Maintains | Buy | Get Alert |
| 11/10/2021 | Buy Now | 151.18% | SVB Leerink | Stephanie Davis Demko | — | Maintains | Outperform | Get Alert |
| 08/31/2021 | Buy Now | 147.69% | Morgan Stanley | Craig Hettenbach | — | Maintains | Equal-Weight | Get Alert |
| 08/26/2021 | Buy Now | 144.2% | JP Morgan | Jackson Ader | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/11/2021 | Buy Now | 116.29% | Raymond James | Brian Peterson | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Doximity (DOCS) stock?
The latest price target for Doximity (NYSE:DOCS) was reported by Wells Fargo on July 18, 2024. The analyst firm set a price target for $19.00 expecting DOCS to fall to within 12 months (a possible -32.50% downside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Doximity (DOCS)?
The latest analyst rating for Doximity (NYSE:DOCS) was provided by Wells Fargo, and Doximity downgraded their underweight rating.
When was the last upgrade for Doximity (DOCS)?
The last upgrade for Doximity Inc happened on April 25, 2024 when JP Morgan raised their price target to $25. JP Morgan previously had an underweight for Doximity Inc.
When was the last downgrade for Doximity (DOCS)?
The last downgrade for Doximity Inc happened on July 18, 2024 when Wells Fargo changed their price target from $27 to $19 for Doximity Inc.
When is the next analyst rating going to be posted or updated for Doximity (DOCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on July 18, 2024 so you should expect the next rating to be made available sometime around July 18, 2025.
Is the Analyst Rating Doximity (DOCS) correct?
While ratings are subjective and will change, the latest Doximity (DOCS) rating was a downgraded with a price target of $27.00 to $19.00. The current price Doximity (DOCS) is trading at is $28.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.